London, UK – 14th of February 2025 – Augnito Omni, the groundbreaking AI-driven ambient medical scribe, is experiencing an unprecedented surge in adoption as NHS, GP (General Practitioner) and private healthcare providers seek more effective, highly customisable, and cost-efficient solutions. Augnito Omni AI is designed to revolutionise the medical documentation of healthcare consultations both in-clinic, through video call, or via telemedicine, offering unparalleled personalisation of text output, allowing hospitals, clinics, and clinicians to optimise workflows and enhancing efficiency worldwide.
As the demand for AI-driven ambient documentation rises, Augnito Omni stands out with features that position it as a leading choice among solutions:
Unmatched Customisation and Personalisation
Unlike other AI medical scribes, Augnito Omni offers an unparalleled level of customisation, ensuring that every medical professional, regardless of specialty, receives patient notes tailored precisely to their needs. From structured patient records and referral letters to medical questionnaires and custom documentation, Omni AI effortlessly adapts to each doctor's workflow. This is possible because Augnito owns and trains its own AI models, allowing for a doctor-centric experience. Where other AI solutions force users to make manual edits repeatedly, Omni AI eliminates this inefficiency by delivering fully personalised documentation.
Industry-Leading Accuracy Across Accents and Languages
One of the most significant advantages of Augnito Omni is its superior ability to accurately understand and transcribe global and regional accents, including Indian English, African English, Welsh, Scottish, Irish, and more. This exceptional accuracy is the result of Augnito AI’s extensive training, leveraging 20+ years of medical transcription expertise from Scribetech UK, which has served the NHS for decades. Additionally, Omni AI can recognise and process all major spoken global languages, allowing foreign patients to communicate in their native tongues while ensuring that English patient notes are seamlessly generated.
Unlimited Usage, Transparent Pricing - No Hidden Costs
Augnito Omni breaks away from the restrictive pricing models of competitors by offering unlimited consultations with no caps on minutes used or reports generated. In an industry where many AI providers impose limits and hidden costs, Scribetech UK remains committed to ethical pricing and transparency.
Dr Jam Gafarov, Business Development Manager at Scribetech UK, shares his perspective:
“At Scribetech, we focus on improving healthcare workflows rather than simply capitalising on AI trends. We’re committed to delivering real value to healthcare professionals, ensuring our solutions enhance efficiency, accuracy, and patient care without the burden of unnecessary costs or complexity. We’re a British-based company and with the help of our product team in India, we want to genuinely improve the NHS. We have employees who use the NHS’s services, and we want to see it prosper, along with private healthcare in the country. We’re dedicated to providing the highest level of ambient voice services with no catches or clauses. With us, you get what you pay for; quality and security.”
With Augnito Omni’s cutting-edge technology, healthcare professionals can now focus on what matters most - patient care - without being burdened by inefficient documentation processes. As adoption continues to surge, Omni is rapidly setting the new standard for ambient AI medical scribing.
ENDS
About Scribetech and Augnito
Scribetech, co-developer of Augnito, has been at the forefront of clinical voice solutions for over two decades, serving the NHS and private healthcare providers. Augnito is a secure, cloud-based AI-driven suite offering 99.3% accuracy in speech-to-text capabilities. Designed for seamless integration into clinical workflows, Augnito products transform medical information into actionable, accessible clinical documentation.
For media enquiries or more information about Augnito Omni AI, please contact ukmarketing@scribetech.co.uk